Annovis Bio, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €1.10B
    R&D expenses
    €4.34B
    EBITDA
    -€20.39M
    D&A
    €4.32
    EBIT
    -€20.43M
    Interest expenses
    €452.29K
    EBT
    -€26.12M
    Tax expenses
    -€4.32
    Net income
    -€26.12M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €542.88M
    Changes in working capital
    -€5.47M
    Operating cash flow
    -€11.41B
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €17.08B
    Debt repayment
    €0.00
    Other financing cash flow
    €6.93B
    Net financing cash flow
    €17.09B
    Foreign exchange effects
    €0.00
    Net change in cash
    €5.68B
    Cash at end of period
    €14.78B
    Free cash flow
    -€11.41B

    Balance sheet

    Cash and cash equivalents
    €14.78B
    Cash and short-term investments
    €14.78B
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €0.00
    Total current assets
    €14.78B
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €18.52B
    Accounts payable
    €840.87M
    Short-term debt
    €0.00
    Other current liabilities
    €1.58B
    Total current liabilities
    €2.42B
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €275.31M
    Total non-current liabilities
    €275.31M
    Total liabilities
    €2.70B
    Common stock
    €1.68M
    Retained earnings
    -€126.53B
    Other equity
    €0.00
    Total equity
    €15.82B
    Total liabilities and shareholders' equity
    €18.52B

    Company information

    Market capitalization
    €34.07M
    Employees
    8
    Enterprise Value
    €31.16M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -0.2% Much better than peer group: -55.3%
    ROA
    -0.1% Much better than peer group: -10,317.0%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -33,476.6%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€3.26M

    Notifications